What We Do

Discover the Market Ready Rx Difference.

Based on our purpose-driven focus, Market Ready Rx supports our clients to achieve their business objectives.

Our services accelerate delivery of product to market by:

  • Reducing ambiguity for our clients to navigate from product concept to commercial launch with our real-world experience to guide strategy and tactical decision-making.
  • Delivering data driven insights through Voice of Customer studies and Advisory boards.
  • Reducing errors based on learnings from prior launch programs.
  • Navigating via the fastest path to market based on past experience and a deep understanding of industry market factors.
  • Eliminating gaps for first-to-market commercial entry by ensuring required launch activities are not missed.

Our experience speaks for itself…

A History of Firsts

  • More than 10 companion diagnostic products launched globally
  • Experience in pre-commercial strategy development
  • Expertise training IVD diagnostic and pharmaceutical sales teams

Novel and first-to-market product launches

  • First PD-L1 IHC for Oncology immunotherapy OPDIVO®
  • FDA approved Companion Diagnostic – HercepTest®
  • Totally automated special stains platform – Artisan®
  • 9 color benchtop Flow Cytometer – Cyan™
  • bDNA HIV viral load automated platform – Versant®

Medical Education and Social Network programs for complex emerging products

  • First FDA approved Companion Diagnostic – HercepTest®
  • E-Learning programs for Pathology

Scientific Collaborations

  • Drive key market adoption priorities utilizing scientific advisors and field market research

Market Assessment Strategy

  • Advisory Board go-to-market strategy development for first dual FISH/ ISH platform launch – Omnis
  • Market Research programs to develop instrument Technical Product Specifications

Automated Instrument Platform acceptance beta testing

  • Labeling multi-site field beta testing programs

Key Relationships in the IVD Industry

  • Over 14 years commercial marketing experience in tissue testing
  • Personal relationships with key opinion leader Pathologists, Histotechnologists and Oncologists driving clinical adoption and practice guidelines in the oncology and tissue testing space
  • Experience defining market acceptance criteria for this sector
  • Exclusive companion diagnostic commercial expert within Latin America
  • Personal relationships with key distributors in Argentina, Brazil, Mexico and Chile
  • Track record of 25-30% year over year growth as Director of Sales, Marketing and Service Director
  • Medical Education webinar development with KOLs
  • Social Network programs for complex emerging products
  • Scientific advisors and field market research are utilized to establish positioning and pricing
  • Qualitative market research to drive strategic go-to-market plan
  • Multi-site Automated Instrument Platform beta testing